Pulse Biosciences, Inc.
PLSE
$25.66
$1.295.27%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -6.59% | 10.07% | -1.13% | -14.13% | 13.36% |
| Total Depreciation and Amortization | -1.54% | 1.17% | -6.23% | -3.53% | -1.39% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -62.73% | 9.01% | 8.25% | -12.86% | -22.88% |
| Change in Net Operating Assets | 131.53% | -883.09% | -47.39% | 130.33% | -232.80% |
| Cash from Operations | 1.08% | -13.16% | -1.81% | 5.28% | -47.87% |
| Capital Expenditure | 68.57% | -69.35% | 39.81% | -128.89% | 15.09% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 100.00% | -- | -- |
| Cash from Investing | 68.57% | -69.35% | 49.59% | -173.33% | 15.09% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 495.54% | -80.62% | -- | -100.00% | -69.32% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 480.58% | -80.62% | -- | -100.00% | -69.28% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 14.25% | -30.03% | 13.88% | -1,141.90% | -96.82% |